Cetaphil Gentle Clear Triple-Action Acne Serum

Description

Cetaphil Acne Gentle Clear Triple-Action Acne Serum contains 0.5% Salicylic Acid as its active ingredient, complemented by Niacinamide and Prebiotic. This formulation is indicated for the treatment of acne and is specifically designed for sensitive skin types. The product is presented in a volume of 1 fluid ounce (30 mL). It is dermatologist recommended and claims to hydrate, soothe, and resurface the skin, aiming to visibly improve breakouts within three days.

Uses and Indications

This drug is indicated for the management of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For new users, it is recommended to conduct a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days. If no discomfort is experienced, the user may proceed with the following application instructions.

Prior to application, the skin should be cleaned thoroughly. The product should then be applied to the entire affected area in a thin layer. The recommended frequency of application is one to three times daily. To minimize the risk of excessive skin drying, it is advisable to start with one application per day. The frequency may be gradually increased to two or three times daily as needed or as directed by a healthcare professional.

In the event that bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the likelihood of skin irritation and dryness may increase when this product is used concurrently with other topical acne medications. In such cases, it is recommended to limit the use to one topical acne treatment at a time to minimize the risk of irritation.

Patients should be cautioned to avoid contact with the eyes. In the event of accidental contact, they should rinse the eyes thoroughly with water to mitigate potential adverse effects.

If patients experience severe irritation, they should discontinue use immediately and consult a healthcare provider for further evaluation and guidance.

In cases of ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay to ensure appropriate management.

Side Effects

Patients using this product should be aware that it is for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne treatment at a time.

Additionally, care should be taken to avoid contact with the eyes. Should contact occur, patients are advised to rinse their eyes thoroughly with water. If irritation becomes severe, patients should discontinue use and consult a healthcare professional for further guidance.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne treatment be utilized at a time. If irritation occurs, discontinuation of additional topical treatments is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne medications.

Packaging & NDC

Below are the non-prescription pack sizes of Cetaphil Gentle Clear Triple-Action Acne Serum (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Cetaphil Gentle Clear Triple-Action Acne Serum in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of this product during pregnancy has not been established. The use of salicylic acid during pregnancy is generally not recommended due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid in pregnant individuals. Therefore, pregnant women should consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement standard supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult poison control centers for additional guidance on management strategies.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. Currently, there are no specified storage or handling instructions provided. It is recommended that healthcare professionals refer to the product's labeling for any additional information regarding supply and storage conditions.

Additional Clinical Information

The route of administration for the medication is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cetaphil Gentle Clear Triple-Action Acne Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)